| Old Articles: <Older 28341-28350 Newer> |
|---|
 |
The Motley Fool
January 29, 2008
Brian Lawler |
Acorda Rides the Wave Acorda Therapeutics announces positive clinical trial data on its lead multiple sclerosis drug.   |
The Motley Fool
January 29, 2008
Rick Aristotle Munarriz |
Don't Sell Disney A Citi analyst downgrades shares of Disney; but was it warranted? |
The Motley Fool
January 29, 2008
Brian Lawler |
Genentech Adds to Avastin's Arsenal Genentech's lead drug Avastin gains another use -- just not the one investors expected. |
The Motley Fool
January 29, 2008
Rich Smith |
Foolish Forecast: Boeing's da Bomb In advance of earnings, analysts and investors wonder if Boeing will make it twenty straight quarters of beating estimates. |
The Motley Fool
January 29, 2008
Matt Koppenheffer |
Over the Top With T. Rowe Price The fund family's solid fourth-quarter earnings reflected its funds' strong performance during a tough time in the market. |
The Motley Fool
January 29, 2008
Rich Smith |
Foolish Forecast: Hugs for Under Armour? In advance of earnings, analysts expect sportswear manufacturer Under Armour to show a big increase in sales and profits. |
The Motley Fool
January 29, 2008
Rick Aristotle Munarriz |
eBay Tries On the Cheap Suit eBay is overhauling its pricing strategy. The good news for sellers is that eBay is slashing listing fees by as much as 50%. But, there's bad news too. |
The Motley Fool
January 29, 2008
Tim Beyers |
Palm Waves Goodbye to Retail Palm announces that it will close seven of its eight stand-alone stores and 26 Airport Wireless stores. |
The Motley Fool
January 29, 2008
David Lee Smith |
Halliburton's Profitable Eastern Tilt With its CEO ensconced in Dubai, Halliburton saw big growth there. |
The Motley Fool
January 29, 2008
Colleen Paulson |
60 Is the New 40 A new reality may be setting in: If 60 really is the new 40, it could spell big trouble for specialty retailers such as Chico's, Coldwater Creek, and Stein Mart. |
| <Older 28341-28350 Newer> Return to current articles. |
